Retrolective studies on the survival of cancer patients treated with mistletoe extracts: A meta-analysis

Explore: The Journal of Science and Healing

Volumn 8, Issue 5, 2012, Pages 277-281

  Ostermann, Thomas ^a   Büssing, Arndt ^a  

^a UNIVERSITY OF WITTEN HERDECKE   (Germany)

Author keywords

cancer; Mistletoe; retrolective studies; survival

Indexed keywords

VISCUM ALBUM EXTRACT;

ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER STAGING; CANCER SURVIVAL; COLORECTAL CANCER; DRUG EFFICACY; DRUG SAFETY; HUMAN; MELANOMA; META ANALYSIS; OVERALL SURVIVAL; PANCREAS CANCER; PRIORITY JOURNAL; SURVIVAL TIME; UNSPECIFIED SIDE EFFECT;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; HUMANS; MISTLETOE; NEOPLASMS; PHYTOTHERAPY; PLANT PREPARATIONS; SURVIVAL; TREATMENT OUTCOME;

EID: 84865720142     PISSN: 15508307     EISSN: 18787541     Source Type: Journal    
DOI: 10.1016/j.explore.2012.06.005     Document Type: Article

References (30)

1. A. Büssing, T. Ostermann, E.A. Neugebauer, P. Heusser Adaptive coping strategies in patients with chronic pain conditions and their interpretation of disease BMC Public Health 10 2010 507
2. M.E. Radina, A.C. Ginter, J. Brandt, J. Swaney, D.R. Longo Breast cancer patients' use of health information in decision making and coping Cancer Nurs 34 2011 E1 E12
3. Y. Matchim, J.M. Armer, B.R. Stewart Mindfulness-based stress reduction among breast cancer survivors: a literature review and discussion Oncol Nurs Forum 38 2011 E61 E71
4. F. Musial, A. Büssing, P. Heusser, K.E. Choi, T. Ostermann Mindfulness-based stress reduction (MBSR) for integrative cancer care: a summary of evidence Forschende Komplementärmedizin 18 2011 192 202
5. K.B. Smith, C.F. Pukall An evidence-based review of yoga as a complementary intervention for patients with cancer Psychooncology 18 2009 465 475
6. A. Büssing Overview on Viscum album L. products A. Büssing, Mistletoe. The Genus Viscum. Medicinal and Aromatic Plants - Industrial Profiles 2000 Harwood Academic Publishers Amsterdam 209 221
7. E. Leva, M. Ephraim, E. Ben-Ayre European and oriental mistletoe: from mythology to contemporary integrative cancer care Eur J Integr Med 3 2011 e133 e137
8. E. Ernst, K. Schmidt, M.K. Steuer-Vogt Mistletoe for cancer? A systematic review of randomised clinical trials Int J Cancer 107 2003 262 267 (Pubitemid 37152907)
9. G.S. Kienle, H. Kiene Complementary cancer therapy: a systematic review of prospective clinical trials on anthroposophic mistletoe extracts Eur J Med Res 12 2007 103 119 (Pubitemid 46564000)
10. M.A. Horneber, G. Bueschel, R. Huber, K. Linde, M. Rostock Mistletoe therapy in oncology Cochrane Database Syst Rev 16 2008 CD003297
11. T. Ostermann, C. Raak, A. Büssing Survival of cancer patients treated with mistletoe extract (Iscador): a systematic literature review BMC Cancer 9 2009 451
12. A. Büssing, C. Raak, T. Ostermann Quality of life and related dimensions in cancer patients treated with mistletoe extract (Iscador): a meta-analysis Evid Based Complement Alternat Med 2012 Article ID:219402
13. C.R. Brewin, C. Bradley Patient preferences and randomised clinical trials BMJ 299 1989 313 315 (Pubitemid 19186677)
14. A.R. Feinstein Clinical Epidemiology The Architecture of Clinical Research 1985 WB Saunders Co Philadelphia
15. S. Martin Retrolektives Studiendesign-ein neues Werkzeug der evidenzbasierten Medizin DMW 130 suppl 2 2005 86 90
16. K.A. Kopciuk, Y.H. Choi, E. Parkhomenko Penetrance of HNPCC-related cancers in a retrolective cohort of 12 large Newfoundland families carrying a MSH2 founder mutation: an evaluation using modified segregation models Hered Cancer Clin Pract 7 2009 16
17. A. Papp, L. Cseke, R. Farkas Chemo-radiotherapy in locally advanced squamous cell oesophageal cancer - are upper third tumours more responsive? Pathol Oncol Res 16 2010 193 200
18. T. Popiela, J. Kulig, J. Hanisch, P.R. Bock Influence of a complementary treatment with oral enzymes on patients with colorectal cancers - an epidemiological retrolective cohort study Cancer Chemother Pharmacol 47 suppl 2001 S55 S63
19. J. Beuth, B. Ost, A. Pakdaman Impact of complementary oral enzyme application on the postoperative treatment results of breast cancer patients - results of an epidemiological multicentre retrolective cohort study Cancer Chemother Pharmacol 47 suppl 2001 S45 S54
20. A. Sakalová, P.R. Bock, L. Dedík Retrolective cohort study of an additive therapy with an oral enzyme preparation in patients with multiple myeloma Cancer Chemother Pharmacol 47 suppl 2001 S38 S44
21. P.R. Bock, W.E. Friedel, J. Hanisch Efficacy and safety of long-term complementary treatment with standardised European mistletoe extract (Viscum album L.) in addition to the conventional adjuvant oncological therapy in patients with primary non-metastatic breast cancer Drug Res 54 2004 456 466 (Pubitemid 39127428)
22. M. Augustin, P.R. Bock, J. Hanisch, M. Karasmann, B. Schneider Safety and efficacy of the long-term adjuvant treatment of primary intermediate-to high-risk malignant melanoma (UICC/AJCC stage II and III) with a standardized fermented European mistletoe (Viscum album L.) extract: results from a multicenter, comparative, eidemiological cohort study in Germany and Switzerland Drug Res 55 2005 38 49 (Pubitemid 40175252)
23. W.E. Friedel, H. Matthes, P.R. Bock, K.S. Zänker Systematic evaluation of the clinical effects of supportive mistletoe treatment within chemo- and/or radiotherapy protocols and long-term mistletoe application in nonmetastatic colorectal carcinoma: multicenter, controlled, observational cohort study J Soc Integr Oncol 7 2009 137 145
24. H. Matthes, W.E. Friedel, P.R. Bock, K.S. Zänker Molecular mistletoe therapy: friend or foe in established anti-tumor protocols? A multicenter, controlled, retrospective pharmaco-Epidemiological study in pancreas cancer Curr Mol Med 10 2010 430 439
25. M. Borenstein, L.V. Hedges Introduction to Meta-Analysis 2009 John Wiley and Sons Chichester
26. C.H. Wiese, U.E. Bartels, Y.A. Zausig, J. Pfirstinger, B.M. Graf, G.G. Hanekop Prehospital emergency treatment of palliative care patients with cardiac arrest: a retrolective investigation Support Care Cancer 18 2010 1287 1292
27. R. Grossarth-Maticek, H. Keine, S. Baumgartner, R. Ziegler Use of Iscador, an extract of European mistletoe (Viscum album), in cancer treatment: prospective nonrandomized and randomized matched-pairstudies nested within a cohort study Altern Ther Health Med 7 2001 57 78 (Pubitemid 32423640)
28. R. Grossarth-Maticek, R. Ziegler Prospective controlled cohort studies on long-term therapy of breast cancer patients with a mistletoe preparation (Iscador) Forschende Komplementarmed 13 2006 285 292 (Pubitemid 44641775)
29. L. Edler Chemotherapy with complementary mistletoe therapy How evident is its effectiveness really? Internist Prax 43 2003 895 904
30. B. Schneider Chemotherapy with complementary mistletoe therapy How evident is its effectiveness really? On the retrolective Studies: Augustin, et al. 2005; Bock, et al. 2004. In reply to L. Edler H. Kiene, H.U. Albonico, G. Kienle, Anthroposophic Medicine Effectiveness, Utility, Costs, Safety 2008 Schattauer-Verlag Stuttgart 293 296